Pressure Point

Pressure Point, Inc. was a medical device company primarily known for developing and marketing the Reliefband, a wearable neuromodulation device used to treat nausea and vomiting. The technology utilizes programmed pulses with specific waveforms and frequencies to stimulate the median nerve, providing a non-invasive, drug-free solution for conditions such as motion sickness, morning sickness, and chemotherapy-induced nausea. Originally developed by Medtronic and later held by Woodside Biomedical, the assets were managed by Pressure Point before being acquired by Reliefband Technologies in 2015. The company's products were among the first wearable electronic devices to receive FDA clearance for the treatment of nausea.